Newron Pharmaceuticals SpA(DE:NP5)
€9.76-0.59 (-5.70%)
DE:NP5
Newron Pharmaceuticals SpA Revenue
€9.76
At close:-0.59 (-5.70%)
Newron Pharmaceuticals SpA (NP5) Revenue
3 Followers
Newron Pharmaceuticals SpA Revenue
Newron Pharmaceuticals SpA had a revenue of 3.17M in the quarter ending Jun 30, 2026, with -56.16%. This bring the company's revenue in the last twelve months to 10.41M, Decreased 45.59%. In the fiscal year ending Dec 31, 2025, Newron Pharmaceuticals SpA had annual revenue of 19.13M with -62.78% growth.
- Revenue (ttm)
- 10.41M
- Revenue Growth
- -82.60%
- P/S Ratio
- 11.04
- Revenue/Employee
- EUR 708,370
- Employees
- 27
- Market Cap
- EUR 211.10M
Revenue Chart
Newron Pharmaceuticals SpA Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 19.13M | -32.26M | -62.78% |
| Dec 31, 2024 | 51.39M | 42.33M | 467.41% |
| Dec 31, 2023 | 9.06M | 2.96M | 48.62% |
| Dec 31, 2022 | 6.09M | 332.00K | 5.76% |
| Dec 31, 2021 | 5.76M | 504.00K | 9.59% |
| Dec 31, 2020 | 5.26M | -1.78M | -25.29% |
| Dec 31, 2019 | 7.04M | 3.01M | 74.86% |
| Dec 31, 2018 | 4.03M | -9.40M | -70.03% |
| Dec 31, 2017 | 13.43M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.